Reuters logo
BRIEF-Zhejiang Wolwo Bio-Pharmaceutical sees FY 2017 H1 net profit to increase by 30 pct to 50 pct
July 14, 2017 / 7:37 AM / 4 months ago

BRIEF-Zhejiang Wolwo Bio-Pharmaceutical sees FY 2017 H1 net profit to increase by 30 pct to 50 pct

July 14(Reuters) - Zhejiang Wolwo Bio-Pharmaceutical Co Ltd :

* Says net profit for FY 2017 H1 to increase by 30 percent to 50 percent, or to be 70.4 million yuan to 81.2 million yuan, compared to net profit of FY 2016 H1 (54.1 million yuan)

* Says increased revenue of main business as main reason for the forecast

Source text in Chinese: goo.gl/B2GNXS

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below